Every sponsor wants to minimise wastage in clinical trial supplies, but the motivation to do so can lack when the product under study is unusually expensive.

A top-tier, international pharmaceutical company engaged Almac to ensure that it did not incur undue drug supply costs for a global study involving a very expensive investigational product.

With some ingenuity and customisations to the IXRS® platform for managing patients, supplies and trial data, Almac helped the client re-envision its study design and supply strategy.

Download this case study to find out more.